Literature DB >> 33548210

Neural crest metabolism: At the crossroads of development and disease.

Debadrita Bhattacharya1, Behram Khan1, Marcos Simoes-Costa2.   

Abstract

The neural crest is a migratory stem cell population that contributes to various tissues and organs during vertebrate embryonic development. These cells possess remarkable developmental plasticity and give rise to many different cell types, including chondrocytes, osteocytes, peripheral neurons, glia, melanocytes, and smooth muscle cells. Although the genetic mechanisms underlying neural crest development have been extensively studied, many facets of this process remain unexplored. One key aspect of cellular physiology that has gained prominence in the context of embryonic development is metabolic regulation. Recent discoveries in neural crest biology suggest that metabolic regulation may play a central role in the formation, migration, and differentiation of these cells. This possibility is further supported by clinical studies that have demonstrated a high prevalence of neural crest anomalies in babies with congenital metabolic disorders. Here, we examine why neural crest development is prone to metabolic disruption and discuss how carbon metabolism regulates developmental processes like epithelial-to-mesenchymal transition (EMT) and cell migration. Finally, we explore how understanding neural crest metabolism may inform upon the etiology of several congenital birth defects.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aerobic glycolysis; Birth Defects; Carbon metabolism; Cell migration; Diabetes; EMT; Glycolysis; Neural crest; Neurocristopathies; Warburg Effect

Year:  2021        PMID: 33548210     DOI: 10.1016/j.ydbio.2021.01.018

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  1 in total

1.  Shorter periconception maternal telomere length and the risk of congenital cardiac outflow defects in the offspring.

Authors:  Damiat Aoulad Fares; Rosalieke E Wiegel; Alex J Eggink; Sten P Willemsen; Joyce B J van Meurs; Régine P M Steegers-Theunissen
Journal:  Eur J Clin Invest       Date:  2022-04-11       Impact factor: 5.722

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.